Author

Ben Baker

Observed names: B. Baker, S. Ben Baker

Institution: Vaxxas (Australia)

Observed institutions: Translational Research Institute, The University of Queensland, Vaxxas (Australia)

ORCID: 0000-0003-1561-3013

Observed ORCID: 0000-0003-1561-3013

OpenAlex ID: A5044905669

Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment

2019 · Brian K. Meyer, Mark A.F. Kendall, et al. · Vaccine X · 30

Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial

2023 · S. Ben Baker, Imogen Bermingham, et al. · Vaccines · 25

Innate local response and tissue recovery following application of high density microarray patches to human skin

2020 · David A. Muller, Joakim Henricson, et al. · Scientific Reports · 24

M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)

2020 · Jamie-Lee S. Mills, Cesar M. Jayashi Flores, et al. · npj Vaccines · 20

Evaluation of the self-administration potential of high-density microarray patches to human skin: A preliminary study

2023 · B. Baker, E. Hacker, et al. · Human Vaccines & Immunotherapeutics · 14

Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates

2023 · E. Hacker, B. Baker, et al. · Vaccine · 11

Local Response and Barrier Recovery in Elderly Skin Following the Application of High-Density Microarray Patches

2022 · Fredrik Iredahl, David A. Muller, et al. · Vaccines · 7

Micropuncture closure following high density microarray patch application in healthy subjects

2022 · Joakim Henricson, David A. Muller, et al. · Skin Research and Technology · 5

Vaccine microarray patch self-administration: A preliminary study in adults 50 years of age and over

2025 · C. Davies, B. Baker, et al. · Vaccine · 4

Benefits and challenges of high-density microarray patches for vaccination among older adults: A qualitative study

2025 · Matthew N. Berger, Sara L. Knox, et al. · Health Policy and Technology

Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)

2020 · Jamie-Lee S. Mills, Cesar M. Jayashi Flores, et al. · npj Vaccines

Works count: 11

Citation count: 140

H-index: 7

I10-index: 6